Healthy Participants trials recruiting in California

All Healthy Participants trials nationally

Cities in California

Recruiting trials in California

• A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.
  NCT07511205 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Glendale
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
  NCT06980428 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · California: Glendale
• A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
  NCT07013643 · Phase: Phase 1 · Ages: 35 Years to 75 Years · Sex: Female · California: Glendale
• A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
  NCT07723833 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · California: Glendale
• FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
  NCT06564389 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · California: Anaheim, San Diego
• Fructose Intestinal Gluconeogenesis
  NCT07209202 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 55 Years · Sex: All (male and female) · California: Vallejo
• Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia
  NCT07344948 · Phase: Early Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · California: Los Alamitos